Page 120 - Read Online

Fang. J Cancer Metastasis Treat 2020;6:1 I http://dx.doi.org/10.20517/2394-4722.2019.42 Page 3 of 3

biomarkers in liquid biopsy. J Cancer Metastasis Treat 2019;5:65.
5. Huang QQ, Chen XX, Jiang W, Jin SL, Wang XY, et al. Sensitive and specific detection of circulating tumor cells promotes precision
medicine for cancer. J Cancer Metastasis Treat 2019;5:34.
6. Bookland MJ, Kolmakova A. Peripheral biomarkers for pediatric brain tumors: current advancements and future challenges. J Cancer
Metastasis Treat 2019;5:33.
7. Farlow JL, Birkeland AC, Swiecicki PL, Brenner JC, Spector ME. Window of opportunity trials in head and neck cancer. J Cancer
Metastasis Treat 2019;5:18.
8. Vander Borght A, Duysinx M, Ummelen M, van der Zeijst BAM. Monoclonal antibodies to the exon 18 encoded moiety of NCAM. J
Cancer Metastasis Treat 2019;5:57.
9. Ossoliński K, Nizioł J, Arendowski A, Ossolińska A, Ossoliński T, et al. Mass spectrometry-based metabolomic profiling of prostate cancer
- a pilot study. J Cancer Metastasis Treat 2019;5:1.
10. Zaichick V, Zaichick S. Levels of chemical element contents in thyroid as potential biomarkers for cancer diagnosis (a preliminary study). J
Cancer Metastasis Treat 2018;4:60.
11. Liu CH, Wu B, Sordillo LA, Boydston-White S, Sriramoju V, et al. A pilot study for distinguishing basal cell carcinoma from normal human
skin tissues using visible resonance Raman spectroscopy. J Cancer Metastasis Treat 2019;5:4.